Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Forschungsprojekte
ACCOST: Adrecizumab in Cardiogenic Shock
Karakas, M., Karakas, M. & Sehner, S.
01.03.19 → 31.12.27
Projekt: Forschung